醫療保健 · Healthcare
開啟互動頁面（K 線、成交價圖）Open interactive page →
HALO · HALOZYME THERAPEUTICS, INC.
內部人交易（Form 4）· Insider trading · 2026-07-01 – 2026-10-22
HALOZYME THERAPEUTICS, INC.（HALO）內部人交易：2026-07-01 至 2026-10-22，內部人公開市場買入 —、賣出 $22.4M；高管董事有效買入 —、有效賣出 —。最近申報 2026-10-08。
買入 Bought—
賣出 Sold$22.4M
有效買入 Effective bought—
有效賣出 Effective sold—
最近申報 Recent filings
| 交易日 | 內部人 | 類型 | 股數 | 價格 | 金額 | |
|---|---|---|---|---|---|---|
| 2026-10-06 | Torley Helen Director, PRESIDENT AND CEO | 賣出 Sell | 60,000 | $110.18 | $6.6M | SEC |
| 2026-10-01 | Posard Matthew L. Director | 賣出 Sell | 5,230 | $108.54 | $568K | SEC |
| 2026-09-16 | Posard Matthew L. Director | 賣出 Sell | 18,996 | $107.74 | $2.0M | SEC |
| 2026-09-09 | Torley Helen Director, PRESIDENT AND CEO | 賣出 Sell | 60,000 | $107.28 | $6.4M | SEC |
| 2026-08-17 | Torley Helen Director, PRESIDENT AND CEO | 賣出 Sell | 60,000 | $104.59 | $6.3M | SEC |
| 2026-08-10 | Connaughton Bernadette Director | 賣出 Sell | 1,626 | $102.80 | $167K | SEC |
| 2026-07-08 | Torley Helen Director, PRESIDENT AND CEO | 賣出 Sell | 1,923 | $79.77 | $153K | SEC |
| 2026-07-01 | Connaughton Bernadette Director | 賣出 Sell | 1,625 | $76.71 | $125K | SEC |
「有效」= 高管或董事的公開市場主動買賣，排除 10b5-1 計劃、行權賣出、繳稅賣出、IPO/認購等。
擬出售 Form 144
| 預計出售日 | 申報人 | 股數 | 約金額 | |
|---|---|---|---|---|
| 2026-09-16 | Posard Matthew L. Director | 34,226 | $3.6M | 10b5-1 |
| 2026-08-17 | Torley Helen President, CEO, Director | 240,000 | $23.7M | 10b5-1 |
| 2026-08-11 | Caudill Cortney Officer | 41,702 | $4.3M | |
| 2026-08-10 | Connaughton Bernadette Director | 1,626 | $168K | 10b5-1 |
內部人 Insiders
Torley Helen、Posard Matthew L.、Connaughton Bernadette